Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Recce Pharmaceuticals Logo
Recce Pharmaceuticals Growth Score
74
CB Rank
144190
Heat Score
66
Recce Pharmaceuticals is a world leader in synthetic polymer-antibiotics
Founded
obfuscation
PublicPost-IPO Equity Sydney, New South Wales, Australia11-50 recce.com.au/
Biotechnology
Pharmaceutical
Overview

Recce Pharmaceuticals
Total Funding
obfuscation
Growth Score
74
Heat Score
66

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score74
2 pts
in past quarter
Heat Score 66
13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Recce Pharmaceuticals

CB Rank
144190
Recce Pharmaceuticals is a world leader in synthetic polymer-antibiotics
Founded
obfuscation
PublicPost-IPO Equity Sydney, New South Wales, Australia11-50 recce.com.au/
Biotechnology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Recce Pharmaceuticals Ltd
Operating Status Active
Stock Symbol  ASX:RCE
Company Type For Profit
Founders  Graham Melrose
About the Company
Recce Pharmaceuticals is a world leader in synthetic polymer-antibiotics. The Company is developing a new class of broad spectrum antibiotics targeting superbugs.
Phone Number +61 (2) 8075 4585
Contact Email james.graham@recce.com.au
Predictions & Insights

Products & Services

Synthetic Polymer-Antibiotics
Synthetic polymer-antibiotics designed to combat bacterial infections by disrupting bacterial membranes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Recce Pharmaceuticals Logo
Post-IPO Equity - Recce Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Recce Pharmaceuticals Logo
Grant - Recce Pharmaceuticals
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Recce Pharmaceuticals Logo
Grant - Recce Pharmaceuticals
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Recce Pharmaceuticals Logo
Grant - Recce Pharmaceuticals
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Recce Pharmaceuticals Logo
Grant - Recce Pharmaceuticals
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Recce Pharmaceuticals Logo
Grant - Recce Pharmaceuticals
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 10

Employee Profiles

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 18, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

667
7.06%
 in past month

Active Website Tech Count

17Recce Pharmaceuticals is actively using 17 technologies for its website, according to BuiltWith. These include Common Crawl, HSTS, and  DNSSEC.

Total IP

9The intellectual property of Recce Pharmaceuticals includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Recce Pharmaceuticals has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Recce Pharmaceuticals's headquarters? Recce Pharmaceuticals is located in Sydney, New South Wales, Australia.Who invested in Recce Pharmaceuticals? Recce Pharmaceuticals is funded by U.S. Department of Defense.When was the last funding round for Recce Pharmaceuticals? Recce Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Recce Pharmaceuticals's competitors? Alternatives and possible competitors to Recce Pharmaceuticals may include Respirion Pharmaceuticals, Kainomyx, and  Phytex.How much funding has Recce Pharmaceuticals raised to date? Recce Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|